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Background: Methylation on the fifth position of cytosine (5-mC) is an essential epigenetic mark that is linked to
both normal neurodevelopment and neurological diseases. The recent identification of another modified form of
cytosine, 5-hydroxymethylcytosine (5-hmC), in both stem cells and post-mitotic neurons, raises new questions as to
the role of this base in mediating epigenetic effects. Genomic studies of these marks using model systems are
limited, particularly with array-based tools, because the standard method of detecting DNA methylation cannot
distinguish between 5-mC and 5-hmC and most methods have been developed to only survey the human genome.
Results: We show that non-human data generated using the optimization of a widely used human DNA methylation
array, designed only to detect 5-mC, reproducibly distinguishes tissue types within and between chimpanzee, rhesus,
and mouse, with correlations near the human DNA level (R2 > 0.99). Genome-wide methylation analysis, using this
approach, reveals 6,102 differentially methylated loci between rhesus placental and fetal tissues with pathways
analysis significantly overrepresented for developmental processes. Restricting the analysis to oncogenes and
tumor suppressor genes finds 76 differentially methylated loci, suggesting that rhesus placental tissue carries a
cancer epigenetic signature. Similarly, adapting the assay to detect 5-hmC finds highly reproducible 5-hmC levels within
human, rhesus, and mouse brain tissue that is species-specific with a hierarchical abundance among the three species
(human > rhesus >> mouse). Annotation of 5-hmC with respect to gene structure reveals a significant prevalence in
the 3'UTR and an association with chromatin-related ontological terms, suggesting an epigenetic feedback loop
mechanism for 5-hmC.
Conclusions: Together, these data show that this array-based methylation assay is generalizable to all mammals for
the detection of both 5-mC and 5-hmC, greatly improving the utility of mammalian model systems to study the role of
epigenetics in human health, disease, and evolution.
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DNA methylation and histone modifications are essential
epigenetic components in the establishment of the tran-
scriptional state of eukaryotic genes throughout the gen-
ome. The best understood of these epigenetic modifications
is DNA methylation, which occurs primarily at cyto-
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stated.of differentiated eukaryotic nuclei [1]. This modifica-
tion is less common in CpG-rich areas, known as CpG
islands, which are often located in the promoter regions
of many genes and involved in transcriptional regula-
tion. While DNA methylation is a hallmark of human
cancer [2], the identification of a growing number of
human diseases resulting from epigenetic disruptions
emphasizes the importance of this mark [3-7].
The recent identification of another modified form of
cytosine, 5-hydroxymethylcytosine (5-hmC), in both stem
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5-hmC is mediated by members of the ten-eleven trans-
location (TET) family of proteins, which each contain a C-
terminal oxidase domain. Recently, a highly efficient and
selective chemical approach to label and capture
5-hmC revealed the first distribution map of 5-hmC in a
mammalian brain genome (mouse) and showed that
5-hmC is enriched in the gene bodies of active or highly
transcribed genes [8]. Furthermore, acquisition of 5-hmC
in specific gene bodies occurs during neuronal differenti-
ation and maturation, indicating that this mark may be
distributed in a spatial and temporal manner in brain dur-
ing development.
Traditionally, non-human studies of DNA methyla-
tion have relied heavily on the ‘gold standard’ for
DNA methylation detection: treatment of genomic
DNA with sodium bisulfite, amplification of the gene
(s)/region(s) of interest, and sequencing the resulting
amplicons [9]. While this method is robust, it is sub-
ject to amplification biases and considered very la-
borious, allowing only for a limited number of sites
to be interrogated at a time. The introduction of
genome-wide arrays and ‘Next-Generation’ sequencing
technologies permits genome-wide interrogation of
5-methylcytosine (5-mC) but these methodologies
either focus solely on human studies (arrays), do
not provide base resolution (enrichment techniques),
or are cost prohibitive (whole genome sequencing).
In addition, these methods could not distinguish
between 5-mC and 5-hmC; however, numerous
sequencing-based methods have recently emerged that
now allow for the quantitative discrimination of the
two modified bases [10,11]. In this study we com-
bined these recent 5-hmC detection methods with
standard array-based methods to develop a novel use
for the HumanMethylation450 BeadChip from Illu-
mina to measure both 5-mC and 5-hmC in mamma-
lian model systems.
Non-human primates (e.g. rhesus monkeys) and
humans have structural and functional similarities in the
neural circuits mediating neuropsychiatric disease. Ac-
cess to relevant brain regions associated with neuro-
psychiatric disorders from a monkey model improves
our ability to translate research findings to humans and
provides opportunities to test hypotheses that cannot be
tested in humans. However, genome-wide molecular ap-
proaches, such as array based assays, in non-human ge-
nomes have not matched resources aimed at the human
genome. Here, we optimized an established human array
that was originally designed to detect 5-mC levels at
nearly half a million loci throughout the human genome
and show that it is also capable of measuring genome-
wide DNA methylation levels in other species, including
non-human primates and mice.Results
Assay optimization
To overcome the paucity of molecular tools for DNA
methylation detection in non-human primates, we opti-
mized a highly reproducible and widely used human
array [12-16] to measure genome-wide DNA methyla-
tion levels in rhesus macaque (Macaca mulatta). The
human array is designed to provide a quantitative meas-
ure of 5-methylcytocine (DNA methylation; 5-mC) at
485,512 CpG dinucleotides located proximal to nearly all
human RefSeq genes (N = 21,231). We interrogated each
fifty nucleotide probe sequence on the array to deter-
mine the fraction that had either an exact match or up
to four mismatches to the rhesus genome and found that
approximately 7% and 30%, respectively, of the array
probes met this criteria, (rhesus-competent probes; exact
match: N = 35,901; mismatch: N = 154,030; Additional
file 1; see Methods). We hypothesized that both sets of
these rhesus-competent probes should reproducibly pro-
vide a quantitative measure of DNA methylation at the
majority (exact match: > 55%, N = 11,804; mismatch > 90%,
N = 19,362) of the human annotated RefSeq genes in
the rhesus genome. Indeed filtering the array probes to
only the rhesus-competent probes reduces the median
number of CpG dinucleotides interrogated per gene
from fifteen (human) to two or six (rhesus exact match
or mismatch, respectively; Additional file 2A).
Using only the rhesus-competent probes, we tested
the reproducibility of this array on monkey DNAs ex-
tracted from skin biopsies of two healthy monkeys and
found that each monkey’s replicates (N = 3) were highly
correlated to each other regardless of the rhesus probe
set (exact match or mismatch), with R2-values similar
to those found among human replicates for this assay
(R2 > 0.99; Figure 1A-B). Notably, the methylation levels
of the rhesus probes were significantly correlated to the
levels found in humans (Figure 1D). Together, these
data suggested that both rhesus-competent probe sets
within this assay are capable of providing an accurate
quantitative measure of DNA methylation throughout
the rhesus genome. As a further test of this conclusion,
we used only rhesus-competent probes with data passing
stringent quality control (exact match: N = 35,750; mis-
match: N = 148,850; Methods) and investigated whether
the rhesus-competent probes were capable of distinguish-
ing between placental and fetal (heart and liver) tissues
from five pregnancies. This analysis revealed, regard-
less of probe set, a clear hierarchical distinction of pla-
centa and fetal tissues, as well as between the two fetal
tissues (Figure 2), indicating that the rhesus-competent
probes have robust tissue-distinguishing properties simi-
lar to those found when the full set of array probes are
used in human studies [17]. Finding that both rhesus-
competent probe sets generated correlations > 0.99 and
Figure 1 Rhesus and mouse DNA methylation levels detected on the human array are highly correlated. Scatter plots of rhesus (A-B) and
mouse (C) methylation data (5-mC) generated from technical replicates run on the HumanMethylation450 BeadChips are shown for exact match
(A; N = 35,901) and mismatch (B; N = 154,030) rhesus-competent probes, or mismatch mouse-competent probes (C; N = 9,734). D) Scatter plot of
the 5-mC levels of the rhesus-competent probes compared to the levels found in humans. Each probe is represented as a colored dot that are
mostly light blue but become dark blue, green, yellow, or red as the density of loci increases. For all plots, the diagonal red line indicates the
regression line and the x and y-axes indicate the methylation level for each replicate (A-C) or the median methylation values of the samples for
each species (D).
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Figure 2 Rhesus-competent probes distinguish monkey tissues. Unsupervised hierarchical cluster analyses of methylation data generated for
placenta and fetal tissues are shown for exact match (A; N = 35,901) or mismatch (B; N = 154,030) rhesus-competent probes. The length of the
branches using the scale shown indicates relatedness.
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identical (Figure 2) suggested that the use of both sets
was redundant. While we conducted all subsequent ana-
lyses with both probe sets and found nearly identical re-
sults, we only present the data from the more
comprehensive set of rhesus-competent probes, the mis-
match set (N = 148,850).
Genome-wide DNA methylation analysis in
rhesus macaque
Placental tissue has drawn biological and gene expres-
sion analogies to malignant tissues [18-22]. A recent study
used the traditional DNA methylation detection method
(locus-specific sodium bisulfite sequencing) to compare
the promoter regions of nine tumor suppressor genes in
placental and fetal tissue and only found hypermethylation
in the promoter of the Ras association domain family 1 A
(RASSF1A) gene [23]. We determined that there are sev-
eral rhesus-competent probes (N = 117) residing through-
out the nine tumor suppressor genes interrogated by
Chiu et al. (Additional file 3) and that these probes
were able to distinguish between all three tissue types,
particularly the fetal from the placental tissues (Figure 3A).
Thus, we conducted a linear mixed-effects regression
analysis (see Methods) on this restricted set of probesand found differential methylation throughout RASSF1
(N = 10; Figure 3B and Additional file 3) and several of
the other tumor suppressor genes previously tested
(MGMT (N = 7), DAPK1 (N = 3), and CDKN2B (N = 2);
Additional file 3). Indeed, this assay simultaneously in-
terrogates additional regions that were not investigated
by Chiu and colleagues, which underscores the more
comprehensive potential of this assay for DNA methy-
lation detection in the rhesus macaque genome. Inde-
pendent analysis of sodium bisulfite converted DNA
spanning the genomic region interrogated by this assay
corresponded well with the β values generated by the
array (Additional file 2C-G), again validating the accur-
acy of this array and this set of probes to measure DNA
methylation levels in the rhesus genome.
To further explore the potential of this assay, we used
the rhesus-competent probes to conduct a genome-wide
regression analysis of methylation levels between pla-
cental and fetal tissue and identified 6,102 differentially
methylated loci (Bonferroni <0.05; Additional file 4).
To statistically validate our methods and adjust for
possible failure of asymptotic assumptions due to the
small sample size, we performed one hundred permu-
tations of the data and found that there was a high cor-
relation between the asymptotic P-values and the
Figure 3 Cancer-related loci distinguish tissues due to significant differential methylation. (A) Unsupervised hierarchical cluster and
heatmap of methylation levels at a limited set of cancer-loci previously investigated in placental tissue by Chui et al. [23]. The cluster tree indicates
the relatedness of the three tissues (x-axis) or the methylation levels (y-axis). The heatmap uses a color scale to indicate the relative methylation
level at each locus. Each row of colored lines (N = 117) represents the methylation level for each CpG locus: red for hypomethylated and yellow
for hypermethylated (see legend). Each column (n = 13) corresponds to each tissue. (B) Relative locations of RASSF1 methylation. Top panel shows
the methylation levels (y-axis) in placenta (orange squares) and fetal (blue crosses) tissues at several loci annotated in or near the RASSF1 locus.
Shown below are the relative CpG coverage (vertical black lines) and CpG island location (green rectangle). Bottom panel depicts a partial gene
schematic of RASSF1, indicating the relative location of the RASSF1 transcription start site (TSS) and exon 1. The genomic position shown below is
relative to HG-19 coordinates.
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file 4; Methods). Annotation of the differentially meth-
ylated loci using gene ontology and Kyoto encyclopedia
of genes and genomes (KEGG) pathways revealed bio-
logically relevant terms that were significantly overrepre-
sented for developmental processes (Additional file 5).
However, the KEGG analysis did not find an overrepresen-
tation of cancer related terms, suggesting that normal tis-
sue differentiation is the primary purpose of the different
methylation marks. Nonetheless, we restricted the probes
used in the regression analysis to those annotated to onco-
genes and tumor suppressor genes and identified cancer-
specific differentially methylated loci (N = 76; Additional
file 6), suggesting placental tissue carries a cancer epigen-
etic signature.
Species-specific methylation marks
These findings led us to test the hypothesis that other
species-competent probe sets could be identified and
used to study genome-wide DNA methylation. Thus we
conducted a similar probe analysis to identify competent
probes for the mouse (N = 9,734; Additional file 1) andthe chimpanzee (N = 360,491; Additional file 1). Using
the mouse-competent probes, we tested the reproduci-
bility of this array and found that each mouse’s repli-
cates (N = 3) were highly correlated to each other, with
R2-values similar to those found among human and
rhesus replicates for this assay (R2 > 0.99; Figure 1). In
addition, using each set of species-competent probes
(human, chimpanzee, rhesus, and mouse), we compared
the consistency of this array between individuals of the
same species (N = 3) and showed that there is a simi-
larly high consistency among individuals of the same
species (mean R2 > 0.90; Additional file 7), and that a
set of common probes (N = 8,189) can clearly distin-
guish the species from one another (Additional file 8A).
Furthermore, we investigated the gene structure distri-
bution of the species-specific probes (i.e. monkey and
mouse; Additional file 9). To test the significance of
this probe distribution in monkey and mouse we com-
pared the proportion of CpG loci that reside in each
structure to the total number of CpG loci interrogated
on the DNA methylation panel via permutation testing.
We found that the optimization in both monkey and
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conserved gene structures (i.e. 5’ UTR, 1st exon, and
gene body regions). This finding is consistent with the
probe selection method used to optimize the assay, which
requires that the species-specific probes be a near match
to the human array (allowing for only a four base mis-
match), meaning that conserved genomic structures are
going to be preferentially retained and that the analyses of
non-human genomes are going to be limited to these re-
gions. Together, these data suggest that this optimization
method is generalizable to any sequenced mammalian
species, making genome-wide DNA methylation detection
possible for a much broader group of species.
Novel utility of the array
The recent characterization of 5-hydroxymethylcytosine
(5-hmC) in both stem cells and post-mitotic neurons,
has led to a flurry of studies aimed to determine the role
of this base in mediating epigenetic effects [8,24-28].
While numerous recent methods have emerged that are
capable of providing base-resolution of 5-hmC, these
methods are sequencing-based, making them laborious
and cost prohibitive [10,11]. Thus, we sought to deter-
mine if the aforementioned human DNA methylation array
(HumanMethylation450 BeadChips; Illumina), which is
designed to detect 5-mC, could also report 5-hmC levels
throughout the genome. To test this hypothesis, we treated
human brain DNA with β-glucosyltransferase and re-
combinant mouse Tet1 (mTET), prior to following the
standard array protocol (Methods), and found that rep-
licates (N = 3) were highly correlated to each other, with
R2-values similar to those found for 5-mC detection
among human replicates (mean R2 > 0.95; Figure 4A).
In comparison to the 5-mC levels in these samples (me-
dian = 53%), the median 5-hmC levels are much lower
(21%), as the majority of the loci are < 40% 5’-hydroxy-
methylated (Figure 4B). Since independent analysis of
5-hmC (Methods) in these tissues validated the accur-
acy of the assay (Additional file 2H-M), these data sug-
gest that this array is capable of providing a quantitative
measure of 5-hmC throughout the human genome.
This finding prompted us to investigate whether the
array could accurately detect 5-hmC in other mamma-
lian genomes and we found that it provides a consistent
quantitative measure of 5-hmC throughout both the mon-
key and mouse brain genomes (Additional file 8C-D);
again suggesting that optimizing this assay is generalizable
to any sequenced mammalian species. Comparison with
the human 5-hmC profiles also revealed several inter-
esting biological findings, including that 5-hmC profiles
clearly distinguish between species (N = 8,189 probes;
Additional file 8B) and that the primate median 5-hmC
levels are highly correlated (Figure 4C). Thus, despite
the fact that there are species-distinguishing 5-hmCmarks, the majority of marks have a consistent level of
5-hmC, at least in primates (Figure 4D), suggesting that
there is likely to be a significant overlap of primate
genes with abundant 5-hmC levels. Consistent with this
rationale, we found that primates indeed have a significant
overlap of probes with > 20% 5-hmC levels (Figure 4E).
In addition, primates have significantly more probes with
> 20% 5-hmC than mice (53% (human), 42% (monkey),
and 17% (mouse); Figure 4D), suggesting that this mark
may play a larger role in primates than mice. Together,
these data show that this array-based assay has a broad
utility in DNA methylation studies of both 5-mC and
5-hmC.
Hydroxymethylation and genomic context
The locations of methylated cytosines are often referred
to with respect to either a CpG island or a gene. In
regards to CpG islands, methylation is either on the is-
land, on the island shores or on the island shelves (0-2
or 2-4 kilobases flanking the island, respectively; [29]).
Recent studies of 5-hmC in human embryonic stem cells
(hESCs) have been contradictory regarding the 5-hmC level
on CpG islands, with the most recent report showing that
CpG islands are deficient of 5-hmC [10,11,25,26,30,31].
However, studies of 5-hmC levels in mouse hippocampal
and cerebellum tissue revealed that the prevalence of
5-hmC on a CpG island is determined in relation to the
nearest gene, meaning 5-hmC is depleted on islands associ-
ated with a transcription start site (TSS) but enriched on
intragenic islands [8]. To determine the distribution of 5-
hmC relative to CpG islands in our human, monkey and
mouse brain tissues we compared the proportion of CpG
loci with > 20% 5-hmC that reside in or around CpG
islands to the total number of CpG loci interrogated on the
DNA methylation panel via permutation testing (see
Methods). We found that all species have a significant
overrepresentation of 5-hmC on the island shelves
(P < 0.0001) and a significant underrepresentation on the
islands (P < 0.0001; Figure 5A-E, Additional file 10 and
Additional file 11). However, when the CpGs on islands
were segregated into associated or not associated with a
TSS, we found in all species that probes in islands associ-
ated with a TSS have a lower 5-hmC level (P < 0.0001). To-
gether, these data show a consistent genome distribution of
5-hmC among species and support previous data from
hESCs and mouse brain tissue, further validating this array
for studies of 5-hmC.
Locations of DNA methylation relative to a gene refer
to regions that include the distance to the gene TSS
(TSS1500 (i.e. within 1500 bp of the TSS) and TSS200),
5’UTR, 1st exon, body, and 3’UTR. Previous studies of
5-hmC levels in mouse hippocampal and cerebellum tis-
sue revealed that 5-hmC is enriched in gene bodies [8].
Here we found a similar enrichment in the gene body of
A B
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Figure 4 Detection of 5-hmC is highly reproducible and correlated among primates. A) Scatter plots of human brain methylation data
(5-hmC) generated from biological replicates run on the HumanMethylation450 BeadChips are shown to have a mean R2 > 0.95. Data for each
probe is represented as a blue dot. For all scatter plots, the diagonal red line indicates the regression line and the x and y-axes indicate the
methylation level for each replicate (A) or the median methylation values of the samples for each species (C). B) The density (y-axis) of probes at
each methylation level (x-axis; beta) in human brain samples (N = 3) that were either interrogated for total methylation (5mc + 5hmc; black line)
or 5-hmC levels (5hmc; blue line). C) Scatter plot showing the 5-hmC correlations between rhesus (y-axis) and human (x-axis) data. Each probe is
represented as a colored dot that are mostly light blue but become dark blue, green, yellow, or red as the density of loci increases. D) The density
(y-axis) of probes at each methylation level (x-axis; beta) in human (red; N = 3), rhesus (blue; N = 7), and mouse (green; N = 3) brain samples that
were either interrogated for total methylation (5mc + 5hmc; left plot) or 5-hmC levels (5hmc; right plot). E) Venn diagram showing the overlap of
the human and rhesus probes with a median 5-hmC level > 20%.
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3’ UTR has more 5-hmC than would be expected by
chance alone (P < 0.0001; Figure 5F-K and Additional file
12). Since we also found a significant underrepresentation
in all other genic regions (P < 0.0001), these data suggest
that a non-stochastic mechanism may prevent 5-hmC
from the 5’ end of genes.
It is well known that specific regions of the genome are
differentially methylated based on the biological functions
of the genes contained within the region, with the most
striking example being X inactivation in females. To deter-
mine if 5-hmC is specific to certain regions of the genome,
we plotted the genomic locations of the 5-hmC and found
that all three species have 5-hmC levels greater than 20%located throughout the genome, but closer examination
suggest a deficit of 5-hmC on the X chromosome (Figure 6
and Additional file 13). To test the significance of these
observations and to determine if other chromosomes
contain a disproportionate number of 5-hmC loci with
levels > 20%, we compared the proportions of these
5-hmC loci for each chromosome using permutation
testing (see Methods) and found that only humans
have chromosomes with a disproportionate number of
loci containing 5-hmC levels > 20%, both with deficits
(X (P < 0.0001) and 18 (P < 0.03); Figure 6 and Additional
file 11). Although the deficit on the X chromosome ap-
proaches significance in monkeys (P < 0.091), these data
suggest that chromosomal deficits are human specific and
Figure 5 The distribution of DNA methylation with respect to CpG islands and gene structures. A-K) The density (y-axis) of probes at each
methylation level (x-axis; beta) in human brain samples that were either interrogated for total methylation (5mc + 5hmc (black line)) or 5-hmC
levels (5hmc (blue line)). A-E) Profiles shown are delineated for the island, the island shores (N_shore (5’ end) and S_shore (3’ end)) or the island
shelves (N_Shelf and S_Shelf, which are defined as 0-2 or 2-4 kilobases flanking the island, respectively. F-I) Profiles shown are delineated relative
to a gene, including the distance to the gene transcription start site (TSS; TSS1500 (i.e. within 1500 bp of the TSS) and TSS200), 5’UTR, 1st exon,
body, and 3’UTR. The number of probes is indicated for each island and gene category.
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the same 5-hmC kinetics as the rest of the genome.
X-linked 5-hmC loci have functions in chromatin modifica-
tions and cell death
In humans the X chromosome was deficient of loci with
high levels of 5-hmC. Annotation of X-linked CpG loci
with > 40% 5-hmC in primates or > 20% in mice using gene
ontology revealed several biologically relevant ontologies
that were significantly overrepresented among all species.
These findings predominately included terms associated
with epigenetic functions including covalent chromatin
modifications and histone acetylation. (Additional file 5; see
Methods). Together, these data suggest that 5-hmC may
play a role in an epigenetic feedback loop. Interestingly, an-
notation of the human X-linked CpG loci with > 60% 5-
hmC using gene ontology revealed several biologically rele-
vant ontologies that were significantly overrepresented for
cell death and apoptotic processes, suggesting that 5-hmC
may target a specific subset of genes on the X chromosome.
Notably, gene ontological analysis of the entire array (N =
21,231 genes) also finds significant terms, suggesting that
the full array may have a bias toward a subset of genes and
that conclusions from ontological analysis should be taken
with caution. Clearly further studies are needed todetermine the diverse functional contributions of 5-hmC in
the mammalian brain.
Discussion
This study optimizes an established human array-based
DNA methylation (5-mC) assay to allow for accurate detec-
tion of 5-mC in non-human primates and mice and, per-
haps more importantly, for the detection of genome-wide
5-hmC in mammals. Optimization of this assay dramatic-
ally improves its utility because now it can be used to sim-
ultaneously investigate genome-wide 5-mC and 5-hmC in
any sequenced mammalian genome. Moreover, since the
analysis of data generated by this array is well established,
this assay will reduce the cost and time of DNA methyla-
tion studies, allowing for a greater utilization of mammalian
model systems to investigate the role of epigenetics in
mammalian biological processes.
This optimization achieved high reproducibility among 5-
mC data generated for chimpanzee, rhesus, and mouse by
utilizing an approach that relied on filtering the data down
to the probes with a near match (allowing for up to 4 mis-
matches) between the human genome and the species of
interest. This filter for species-specific probes still provides
data for > 90% of the human annotated genes in the mon-
key and nearly 25% for the mouse. Finding that the
Figure 6 The range of 5-hmC levels on each chromosome. The distribution of 5-hmC in human brain tissues (N = 3; A-C) is shown using box
and whisker plots depicting the 5-hmC level (y-axis) of probes (N = 485,577) by chromosome (x-axis).
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360,491) is consistent with known evolutionary similarity
with humans but also may reflect the higher quality refer-
ence sequence of the human and chimpanzee genomes
compared to the rhesus genome. Recently, a similar ap-
proach identified 13,715 mouse-competent probes on the
human array [32], which contains nearly 75% of the mouse-
competent probes reported here. Together these independ-
ent findings strongly support the use of this array with
other species. The only other array-based method available
for 5-mC detection in mice (Mouse CpG Island Microarray;
AgilentTechnologies) relies heavily on the efficiency/repro-
ducibility of restriction enzymes and the data is only reports
5-mC methylation at CpG islands, which our data here
clearly shows is lacking the majority of the variable DNA
methylation information (Figure 5).
Having the ability to conduct an epigenome study in wide
variety of sequenced mammals represents a significant new
methodology. Here we compared the output of the opti-
mized genome-wide array to that of a previously reportedlocus-specific study by Chiu et al., both investigating the
epigenetic differences between monkey placenta and fetal
tissue. Clearly the sheer magnitude of data from the array is
not comparable between studies and neither are the con-
clusions. Notably, in 2007, when the Chui et al. study was
conducted, the HumanMethylation450 BeadChips had not
been developed; meaning Chiu and colleagues were using
the molecular tools available at that time. This fact
notwithstanding, while Chui et al. only found methyla-
tion differences in one of the nine interrogated genes
(RASSF1), the much more comprehensive array ap-
proach developed here found differences in four out of
the nine genes. In addition, the array identified differ-
ences in a total of 2,825 genes throughout the gen-
ome, including hypermethylated in cancer 1 (HIC1)
and TIMP metallopeptidase inhibitor 3 (TIMP3), both
of which were previously shown, using a locus-specific
approach, to not be differentially methylated in normal
placental tissue [33]. Together, these data highlight the
dramatic advantage to using the array-based approach
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to be revisited.
It was previously shown that β-glucosyltransferase could
be used to modify an existing array-based protocol for the
detection of 5-hmC [34]. However, in that case the array
was not specifically designed for methylation detection, the
method relied on the efficiency/reproducibility of restric-
tion enzymes, and the data was biased toward CpG islands.
In contrast, using a modified protocol and the Human-
Methylation450 BeadChip largely overcomes these limita-
tions and produces a more reliable unbiased profile of 5-
hmC throughout the genome, providing a new resource for
epigenetic studies.
The density of 5-hmC probes in all three species pro-
files suggests that the bulk of 5-hmC levels are from 20% -
60%, especially for primates (Figure 4D). While it was
expected that the majority of probes would have a low
level of 5-hmC (< 40%), we did not anticipate that, in the
brain, nearly 50% of the primate loci would be > 20%
hydroxymethylated and nearly 20% of human loci would
be > 50% hydroxymethylated. These data suggest that
5-hmC is much more prevalent than previously reported
and that it may play a more significant role in primates
than mice. However, the gene ontological analysis suggests
that this role is in a feedback loop for epigenetic processes
such as histone lysine methylation and that these func-
tions are common to all mammals.
In the brain tissues of all three species we found the dis-
tribution of 5-hmC with relation to gene structure to be
consistent with previous reports that found 5-hmC is espe-
cially prevalent in the regions adjacent to CpG islands (in
the shelves), indicating that the highest levels of 5-hmC are
at regions of the genome with the lowest CpG density. Also
consistent with previous work was the finding that 5-hmC
is more prevalent in gene bodies compared to the 5’ end of
a gene; however, we find that the 3’ UTR is particularly
enriched for this mark, a location that may facilitate a pro-
posed role in a epigenetic feedback loop. At the chromo-
somal level 5-hmC was reported elsewhere to be deficient
from the X chromosome in mouse hippocampal and cere-
bellum tissue. In contrast, we didn’t find a deficiency on
any mouse chromosomes but we did find it is significantly
deficient on the human X and approaching significance on
the monkey X. Although the synteny between human and
mouse X chromosomes is high, the smaller number of loci
from the mouse may have resulted in a higher genome-
wide variance that precluded the mouse X data to reach
significance.
As we learned with genome-wide association studies, suc-
cessful epigenome-wide association studies of complex phe-
notypes are going to require the analysis of a very large
number of individuals (N > 1000). The development of this
assay improves our ability to quickly and reproducibly
analyze the dynamic role of DNA methylation in a largecohort of individuals. This assay also augments the use of
model systems for the study of epigenetic mechanisms
and phenomena that are difficult to study in humans, in-
cluding other recently identified modifications to methyl-
cytosine, namely 5-formylcytosine and 5-carboxylcytosine.
In addition, data from model systems will make it quite
tempting to draw evolutionary conclusions between the
different mammalian species and the gene ontology ana-
lysis shown here suggests that there are more similarities
among species than differences. In short, this optimized
assay holds great promise to improve our understanding
of DNA methylation and its contributions to health, dis-
ease, and evolution.
Conclusions
Here we have developed an array-based assay to detect
5-mC and 5-hmC in mammalian genomes and show that
it is generalizable to all mammals. Using this assay we
find that placental tissue carries a cancer epigenetic sig-
nature, that 5-hmC has a hierarchical abundance among
mammals, and that X-linked loci and the 3’UTR of genes
have a heightened prevalence for 5-hmC. In short, this
optimized assay greatly improves the utility of mamma-
lian model systems for studying the role of epigenetics
in human health, disease, and evolution.
Methods
Tissue acquisition and DNA extraction
Except for the mouse brain tissues (UW IACUC proto-
col #M02529), all other tissues were supplied by other
research groups, including monkey skin and brain tissue
(Dr. Kalin’s group; UW IACUC protocol #G00181), monkey
placental and fetal tissue (Dr. Golos’ group; UW IACUC
protocol #G00245), and human brain tissue (Emory Neuro-
science NINDS Core Facilities; approved by the Emory
Internal Review Board on August 18, 2013 and given
the approval number CR2_IRB00045782). All groups
follow animal housing and experimental procedures that
are in accordance with institutional guidelines. Once ac-
quired, approximately thirty milligrams of tissue was ho-
mogenized with glass beads (Sigma) and DNA extraction
was performed using AllPrep DNA/RNA mini kit (Qiagen).
DNA methylation profiling
Genomic DNA was split into the following two aliquots:
a sodium bisulfite-only (SB-only) aliquot; and a Tet1
treated followed by SB treated aliquot (TAB). The Tet1
treatment was conducted using previously described
methods [11]. Briefly, one microgram (μg) of genomic
DNA was spiked with four nanograms (ng) of synthetic-
ally methylated control DNAs (N = 3). Together, these
DNAs were sonicated to 400 basepairs (bp) using a
Diagenode Bioruptor Plus (Diagenode) and concentrated
to 19 μl (Amicon Ultacel 100 k, Millipore). To mark
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with T4-β-glucosyltransferase (1 μM; Wisegene) and
UDP-glucose (200 μM, Wisegene) at 37°C for 1 hour,
and purified using the QIAquick Nucleotide Removal
Kit (Qiagen). To mark 5-mC, five hundred ng of the glu-
cosylated DNA was oxidized in the presence of recom-
binant mouse Tet1 (0.48 μg/μl; Wisegene) at 37°C for
1 hour followed by enzyme inactivation with protease K
at 50°C for 1 hour. The oxidized DNA was twice purified
(Micro Bio-Spin 30, Bio-Rad; QIAquick PCR Purification
Kit, Qiagen) and eluted in 20 μl of water. SB-treatment
of both aliquots: Five hundred nanograms of genomic
DNA or Tet-treated DNA was sodium bisulfite–treated
for cytosine (C) to thymine (T) conversion using the EZ
DNA Methylation-Gold kit (Zymo Research). The con-
verted DNA was purified and prepped for analysis on
the Illumina HumanMethylation450 BeadChips follow-
ing the manufacturer’s guidelines. Briefly, converted
DNA was amplified, fragmented, and hybridized to the
HumanMethylation450 pool of allele-differentiating oli-
gonucleotides. After a series of extension, ligation, and
cleanup reactions, the DNA was labeled with a fluores-
cent dye. The labeled DNA was then scanned using an
Illumina BeadArray Reader or iScan. Image analysis
and signal determination were performed using the
GenomeStudio software, Methylation Module (Illumina).Interpretation and QC of DNA methylation data
CpG DNA methylation data were interpreted using Geno-
meStudio to quantify methylated (M) and unmethylated
(U) signal intensities for genomic DNA. The signals were
quantile normalized, and overall methylation levels (β)
were calculated as the ratio of methylated to total signal
[i.e. β =M/(M + U + 100)], where β ranges from 0
(unmethylated) to 1 (methylated). For human samples,
quality control of data resulted in removal of samples
with aberrantly low signal intensity (mean < 2000) or with
fewer than 99% of CpG loci detected, where a given locus
was deemed not detected if the detection P-value was
> 0.01 (detection P-value provided by Genome Studio and
calculated relative to background signal). For rhesus,
chimp and mouse samples, the data for only the ‘compe-
tent’ probe-set (ref. section ‘Assay optimization’) for each
species was taken. Furthermore, any probes having
more than 20% of samples with detected P-values > 0.01
were discarded from the analysis. Assay controls were
inspected to remove samples with poor bisulfite con-
version, staining, extension (single nucleotide extension
assay), hybridization, or specificity. Outliers identified
by hierarchical clustering and/or dissimilarity matrices
were removed. Additionally, one control DNA replicate
was run on each BeadChip to assess overall assay re-
producibility. Methylation profiles of the control DNAcorrelated well, with an average Pearson correlation co-
efficient (R) of 0.990 between human replicates.
Analysis of cancer-associated CpG loci
To analyze DNA methylation differences associated with
cancer, we fit a separate regression for each CpG site. Al-
though samples were randomly distributed across Bead-
Chips and experiments with respect to disease, BeadChip
was also included as a random effect covariate in all ana-
lyses to account for potential batch effects. The package
“nlme” in R (Cran) was used for the mixed effect model.
Fixed effects included intensity in the model. To correct
for multiple hypothesis testing, we applied a Benjamini-
Hochberg False Discovery Rate (FDR) correction using
the R function “p.adjust,” but to avoid false positives due
to the small sample size, we used conservative Bonferroni
adjustment for our ultimate determination of significance.
Permutation analyses for rhesus differentially
methylated loci
All permutation analyses were conducted in R using the
same linear model as the actual analysis, where Bead-
Chip was treated as a mixed-effects covariate, but in
each permutation the tissue type of the sample was ran-
domly reassigned. In total, 100 permutations were con-
ducted. Permutation P-values for each CpG locus were
calculated by assessing the number of times each locus
was more significantly associated with fetal tissue in the
100 permuted data sets than the actual.
Analysis of genomic location
Loci were mapped to chromosome location using the Illu-
mina annotation files for the HumanMethylation450 panel
based on the NCBI Human Genome (build 37). Over- and
underrepresentation of CpG loci with > 20% median 5-hmC
were assessed using both Fisher’s exact test and permuta-
tion analysis, which corresponded well (data not shown).
Permutation P-values were determined as described previ-
ously [16], by comparing the proportion of >20% 5-hmC
loci on a chromosome (termed “actual proportion”) to the
proportions obtained using the permuted loci (termed
“permuted proportions”). To correct for multiple hypoth-
eses (i.e. 24 chromosomes and both over and underrepre-
sentation) the actual proportion of each chromosome was
compared to the permuted proportions of any chromo-
some for each permutation. Thus the permutation P-value
is the number of times a permuted proportion is more sig-
nificant than the actual proportion, divided by the number
of permutations (10,000).
Data access
We have submitted the data generated from the monkey,
chimp, human and mouse samples for this study to the
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under the Gene Series: GSE49177.
Additional files
Additional file 1: Optimized probe sets for each species. The list of
Illumina probe identification names that were used for each non-human
species. Header indicates the species and whether these probes were
identified as exact matches or mismatches (see Methods).
Additional file 2: Array-based assay probe distribution and
validation. A) The density (y-axis) of genes and the number of probes
for each gene (x-axis; beta) are shown for human (blue), rhesus (orange),
and mouse (black) genomes. B) Permutation analysis of placenta-associated
differential methylation. Scatter plot of permuted (100 permutations)
placental-associated P-values (x-axis) compared to asymptotic P-values
(y-axis) calculated using the linear model (Pearson R = 0.9852).
C-M) Independent assay validates the accuracy of the array for 5-mC
(rhesus) and 5-hmC (human and rhesus) C-G) Bar charts showing the
side-by-side comparison of the methylation levels (y-axis) of CpG loci near
genes (denoted above each chart) in different monkey tissues that were
determined by either sodium bisulfite treatment, cloning, and sequencing
(white bars) or the HumanMethylation450 BeadChips (black bars). H-M)
Circle plots showing the 5-mC (H, J, L) and 5-hmC (I, K, M) status of individual
CpG loci in human (H-K) and monkey (L-M) genes (denoted above each
plot) from brain tissue. Each circle represents the methylation
status of an independent clone (open circle = unmethylated; closed
circle = methylated). The numbers along the left of each panel indicates
the percent methylation that was determined using either the Human-
Methylation450 BeadChips (Array) or the independent assay (sodium-
bisulfite sequencing; SBS). The numbers along the left indicates the
nucleotide number from the transcription start site of each gene, as
referenced from UCSC build 37/hg19. Each row of the panels indicates
a different clone.
Additional file 3: Differentially methylated loci identified between
rhesus placental and fetal tissue using genes previously
investigated by Chui et al. [23]. Header descriptions include: the
Illumina assay probe identification (cgid); the Bonferroni corrected
P-value (bonferroni); the false discovery rate (fdr); uncorrected P-value
(none); permutation P-value (perm_pvalue); the genome build that the
probe was designed on (Genome_Build); the human chromosome that
the probe is located on (CHR); the genomic coordinates on the human
chromosome (MAPINFO); the gene name as annotated by the University
of California Santa Cruz genome browser (UCSC_RefGene_Name); the




Additional file 4: Genome-wide differentially methylated loci
identified between rhesus placental and fetal tissue. Header
descriptions include: the Illumina assay probe identification (cgid); the
Bonferroni corrected P-value (bonferroni); the false discovery rate (fdr);
uncorrected P-value (cls_pvalue); the genome build that the probe was
designed on (Genome_Build); the human chromosome that the probe is
located on (CHR); the genomic coordinates on the human chromosome
(MAPINFO); the gene name as annotated by the University of California
Santa Cruz genome browser (UCSC_RefGene_Name); the UCSC accession
number for the gene (UCSC_RefGene_Accesssion); the location of the
locus in relation to the UCSC gene structure (UCSC_RefGene_Group); and
the location of the locus in relation to a UCSC annotated CpG island
(Relation_to_UCSC_CpG_Island; blank means no association).
Additional file 5: Output results from gene ontology and KEGG
analysis. This table has five pages that can be accessed using the
labeled tabs at the bottom. The first two tabs are gene ontology
(DML_GeneOntology_Placenta_vs_Fe; tab 1) or KEGG analysis
(DML_KEGG_Placenta_vs_Fetal.csv; tab 2) using the 6,102 loci identified
with the genome-wide regression analysis. The header descriptions
include: the gene ontology or KEGG identification number (GOBPID orKEGGID); the P-value associated with finding this term (Pvalue); the Odds
ratio for the term (OddsRatio); the expected number of genes to be
associated with the term (ExpCount); the actual number of the differentially
methylated genes that are associated with the term (Count); the total
number of genes on the assay associated with the term (Size); and the term
name (Term). The other three pages of this file are the output results from a
gene ontology analysis using the X-linked CpG loci with > 40% 5-hmC in
primates (5hmc_Chr_X_Human_GeneOntology_0; tab 3 (human) and
5hmc_Chr_X_Rhesus_GeneOntology_; tab 4 (monkey)) or > 20% in mice
(5hmc_Chr_X_Mouse_GeneOntology_0; tab 5). Header descriptions are the
same as above for tab 1.
Additional file 6: Differentially methylated loci identified between
rhesus placental and fetal tissue using genes annotated to
oncogenes and tumor suppressor genes. Header descriptions include:
the Illumina assay probe identification (cgid); the Bonferroni corrected
P-value (bonferroni); the false discovery rate (fdr); uncorrected P-value
(cls_pvalue); the genome build that the probe was designed on
(Genome_Build); the human chromosome that the probe is located on
(CHR); the genomic coordinates on the human chromosome (MAPINFO);
the gene name as annotated by the University of California Santa Cruz
genome browser (UCSC_RefGene_Name); the UCSC accession number
for the gene (UCSC_RefGene_Accesssion); the location of the locus in
relation to the UCSC gene structure (UCSC_RefGene_Group); and the
location of the locus in relation to a UCSC annotated CpG island
(Relation_to_UCSC_CpG_Island; blank means no association).
Additional file 7: Mammalian DNA methylation levels detected on
the human array are highly correlated. Scatter plots of human (A),
chimpanzee (B), rhesus (C), and mouse (D) methylation data (5-mC)
generated from biological replicates run on the HumanMethylation450
BeadChips are shown for mismatch species-competent probes
(N = 485,577 (A); 360,491 (B); 154,030 (C), or 9,734 (D)). The diagonal
red line indicates the regression line and the x and y-axes indicate the
methylation level for each individual. The correlation level (R2) is denoted
above each plot.
Additional file 8: 5-hmC distinguishes species and is highly
reproducible among mammals. Unsupervised hierarchical cluster
analyses of 5-mC (A) and 5-hmC (B) probe data common to all species
(N = 8,189) that was generated from brain tissue of human (E06 samples),
monkey (r# samples), and mouse (mA, mB, and mC) individuals are
shown. The length of the branches using the scale shown indicates
relatedness. Scatter plots of rhesus (C) and mouse (D) brain methylation
data (5-hmC) generated from biological replicates run on the
HumanMethylation450 BeadChips are shown to have a mean R2 > 0.92.
Data for each probe is represented as a blue dot. For all scatter plots,
the diagonal red line indicates the regression line and the x and y-axes
indicate the methylation level for each replicate.
Additional file 9: Gene structure specific probe distribution among
species. The density (y-axis) of probes at each annotated gene structure
(x-axis) using the human (blue), rhesus (orange), and mouse (black)
optimization of the array.
Additional file 10: The distribution of DNA methylation with
respect to CpG islands. The density (y-axis) of probes at each
methylation level (x-axis; beta) in monkey (A-E) and mouse (F-J) brain
samples that were either interrogated for total methylation (5mc + 5hmc
(black line)) or 5-hmC levels (5hmc (blue line)). Profiles shown are
delineated for the island, the island shores (N_shore (5’ end) and S_shore
(3’ end)) or the island shelves (N_Shelf and S_Shelf, which are defined as
0-2 or 2-4 kilobases flanking the island, respectively. The number of
probes is indicated for each island category.
Additional file 11: This table displays the output for the analysis of
the locations of methylated cytosines with respect to either a CpG
island or a gene. This table has five pages that can be accessed using the
labeled tabs at the bottom. The first three pages are with regard to CpG
island and gene structures in human (5hmc_Human_Mismatch_pvalues_Reg;
tab 1), monkey (5hmc_Rhesus_Mismatch_pvalues_Reg; tab 2), and
mouse (5hmc_Mouse_Mismatch_pvalues_Reg; tab 3). The last three
tabs are the results from our chromosomal analysis on human
(5hmc_Human_Mismatch_pvalues_Chr; tab 4), monkey
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(5hmc_Mouse_Mismatch_pvalues_Chr; tab 6). All of the pages in
this file have the following header descriptions: a genomic description
of the locus location (Region (tabs 1-3); Chromsome (tabs 4-6)); whether
the data is filter for probes > 20% or > 40% 5-hmC (Cutoff); the total number
of probes in the dataset (NumProbes_Dataset); the number of probes after
the filter has been applied (NumProbes_Cutoff); the number of probes in the
genomic description of interest (NumProbes_Region or NumProbes_Chr); the
number of probes that meet the genomic description and the filter criteria
(NumCommonProbes); the Fisher’s exact test P-value (FisherPvalue); the odd
ratio for the result (OddsRatio); and the permuted P-value (PermPvalue). The
tabs showing the chromosomal analysis also have a column that shows the
variance that the data has for each chromosome (Variance). See text for
definitions of the regions.
Additional file 12: The distribution of DNA methylation with
respect to gene structures. The density (y-axis) of probes at each
methylation level (x-axis; beta) in monkey (A-F) and mouse (G-L) brain
samples that were either interrogated for total methylation (5mc + 5hmc
(black line)) or 5-hmC levels (5hmc (blue line)). Profiles shown are
delineated relative to a gene, including the distance to the gene
transcription start site (TSS; TSS1500 (i.e. within 1500 bp of the TSS) and
TSS200), 5’UTR, 1st exon, body, and 3’UTR. The number of probes is
indicated for each island and gene category.
Additional file 13: The range of 5-hmC levels on each chromosome.
The distribution of 5-hmC in monkey (N = 4; A-D) and mouse (N = 3; E-G)
brain tissues is shown using box and whisker plots depicting the 5-hmC
level (y-axis) of probes by chromosome (x-axis).
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